Increases to Jacobson Pharma Corporation Limited's (HKG:2633) CEO Compensation Might Cool off for now
Aug 21
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 25, 2024
DataAggregated Company Financials
Companies39
- 7D-8.1%
- 3M-8.8%
- 1Y4.0%
- YTD-11.5%
Over the last 7 days, the Pharma industry has dropped 8.1%, driven by CSPC Pharmaceutical Group declining 23%. In the past year, the industry has gained 4.0%. Looking forward, earnings are forecast to grow by 13% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 25 Aug 2024 | HK$417.8b | HK$465.7b | HK$31.1b | 7.1x | 13.4x | 0.9x |
| Tue, 23 Jul 2024 | HK$437.4b | HK$457.5b | HK$32.5b | 7.4x | 13.5x | 1x |
| Thu, 20 Jun 2024 | HK$466.6b | HK$462.8b | HK$33.9b | 7.7x | 13.8x | 1x |
| Sat, 18 May 2024 | HK$487.2b | HK$463.4b | HK$33.7b | 8.8x | 14.4x | 1.1x |
| Mon, 15 Apr 2024 | HK$440.6b | HK$464.9b | HK$33.8b | 7.6x | 13x | 0.9x |
| Wed, 13 Mar 2024 | HK$460.7b | HK$471.2b | HK$33.6b | 7.9x | 13.7x | 1x |
| Fri, 09 Feb 2024 | HK$418.9b | HK$472.9b | HK$33.9b | 6.6x | 12.4x | 0.9x |
| Sun, 07 Jan 2024 | HK$477.1b | HK$472.6b | HK$33.8b | 8.2x | 14.1x | 1x |
| Tue, 05 Dec 2023 | HK$492.8b | HK$472.7b | HK$33.8b | 7.3x | 14.6x | 1x |
| Thu, 02 Nov 2023 | HK$480.7b | HK$468.8b | HK$31.8b | 6.6x | 15.1x | 1x |
| Sat, 30 Sep 2023 | HK$436.5b | HK$469.6b | HK$31.6b | 6.8x | 13.8x | 0.9x |
| Mon, 28 Aug 2023 | HK$424.1b | HK$449.1b | HK$30.0b | 7.8x | 14.1x | 0.9x |
| Wed, 26 Jul 2023 | HK$484.1b | HK$447.4b | HK$28.0b | 9.2x | 17.3x | 1.1x |
| Fri, 23 Jun 2023 | HK$500.8b | HK$447.0b | HK$27.7b | 9.6x | 18.1x | 1.1x |
| Sun, 21 May 2023 | HK$527.3b | HK$450.3b | HK$28.1b | 8.8x | 18.8x | 1.2x |
| Tue, 18 Apr 2023 | HK$579.6b | HK$454.0b | HK$28.9b | 9.4x | 20.1x | 1.3x |
| Thu, 16 Mar 2023 | HK$597.8b | HK$444.7b | HK$34.3b | 9.9x | 17.4x | 1.3x |
| Sat, 11 Feb 2023 | HK$614.7b | HK$447.1b | HK$35.6b | 11x | 17.3x | 1.4x |
| Mon, 09 Jan 2023 | HK$626.2b | HK$445.4b | HK$35.3b | 11.6x | 17.7x | 1.4x |
| Wed, 07 Dec 2022 | HK$596.6b | HK$441.5b | HK$34.7b | 9.7x | 17.2x | 1.4x |
| Fri, 04 Nov 2022 | HK$593.0b | HK$434.6b | HK$33.6b | 9.1x | 17.7x | 1.4x |
| Sun, 02 Oct 2022 | HK$500.1b | HK$514.1b | HK$40.0b | 8.8x | 12.5x | 1x |
| Tue, 30 Aug 2022 | HK$562.6b | HK$521.3b | HK$42.3b | 9.7x | 13.3x | 1.1x |
| Thu, 28 Jul 2022 | HK$602.1b | HK$512.3b | HK$51.8b | 8.2x | 11.6x | 1.2x |
| Sat, 25 Jun 2022 | HK$631.0b | HK$514.6b | HK$51.9b | 9.6x | 12.2x | 1.2x |
| Mon, 23 May 2022 | HK$586.3b | HK$513.4b | HK$52.0b | 8.7x | 11.3x | 1.1x |
| Wed, 20 Apr 2022 | HK$589.3b | HK$525.3b | HK$53.0b | 8.5x | 11.1x | 1.1x |
| Fri, 18 Mar 2022 | HK$624.5b | HK$500.8b | HK$45.3b | 8.6x | 13.8x | 1.2x |
| Sun, 13 Feb 2022 | HK$676.0b | HK$497.4b | HK$43.9b | 9.5x | 15.4x | 1.4x |
| Tue, 11 Jan 2022 | HK$752.6b | HK$496.6b | HK$43.7b | 10x | 17.2x | 1.5x |
| Thu, 09 Dec 2021 | HK$667.8b | HK$496.9b | HK$43.8b | 9.3x | 15.3x | 1.3x |
| Sat, 06 Nov 2021 | HK$661.5b | HK$494.9b | HK$43.3b | 9.1x | 15.3x | 1.3x |
| Mon, 04 Oct 2021 | HK$756.1b | HK$490.5b | HK$42.5b | 9.9x | 17.8x | 1.5x |
| Wed, 01 Sep 2021 | HK$809.7b | HK$489.5b | HK$42.4b | 11.4x | 19.1x | 1.7x |
Price to Earnings Ratio
19.1x
Current Industry PE
- Investors are relatively neutral on the Hong Kong Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 14.9x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.90x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 10% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 0.28% | |
| Healthcare | -5.01% | |
| Pharma | -8.06% | |
| Pharma | -8.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1558 YiChang HEC ChangJiang Pharmaceutical | HK$9.92 | 2.3% +HK$193.6m | 58.2% | PE4x | |
| 950 Lee's Pharmaceutical Holdings | HK$1.23 | 4.2% +HK$29.4m | -12.1% | PE43.4x | |
| 575 Regent Pacific Group | HK$0.55 | 22.2% +HK$22.8m | -50.0% | PS55.4x | |
| 2633 Jacobson Pharma | HK$0.58 | 1.8% +HK$19.8m | -17.1% | PE6.2x | |
| 2161 JBM (Healthcare) | HK$0.93 | 2.2% +HK$16.5m | -19.1% | PE5.9x |